Set a useful goal beyond an ideal-weight number
Turn a vague ideal-weight target into a useful health, function or habit goal with a realistic action and an agreed review point.
Search explainers, questions, and medicine profiles.
The publication’s independent editorial identity, covering weight-management research, treatments and practical strategies. No individual clinician or professional credential is claimed.
How we workMyWeightLab is an independent, evidence-first publication following GLP-1 medicines, obesity-drug research and the practical science of weight management.
This is a publication byline, not a clinician credential. Our articles do not provide diagnosis, prescriptions or individual treatment advice.
We check regulatory documents, trial registries, prescribing information and peer-reviewed research. Trial design, reported results and marketing approval are separate facts. Sponsor announcements are identified as such.
Editorial source review is distinct from independent clinical review. A real reviewer is credited only when their identity and contribution have been verified.
Turn a vague ideal-weight target into a useful health, function or habit goal with a realistic action and an agreed review point.
Review a disrupted week with neutral facts, protect adequate eating and choose one practical adjustment instead of escalating restriction.
Compare Zepbound and Mounjaro using current US and EU indications, safety warnings and practical questions about the supplied product.
Map activity around work, recovery and access, then give aerobic, strength and everyday movement realistic places in your actual week.
Read the dated Wegovy HD FDA approval, STEP UP dose-specific results and tolerability limits, without turning trial quantities into a dosing plan.
Wegovy and Ozempic share semaglutide, but current indications, formulations and instructions differ. Compare the US and EU boundaries.
Prepare for weight maintenance while changes are still underway, with ongoing support, sustainable habits and a plan for rising weight or access gaps.
Tirzepatide and oral contraception: the four-week precautions, vomiting and diarrhea questions, and why advice must match the exact products.
Plan pregnancy safely with weight-loss medicines: product-specific stopping intervals, contraception, unexpected exposure and coordinated follow-up.
Follow a supplement promise to the exact human evidence, read the regulatory limits, and check safety before confusing marketing with treatment.